• Study of Pembrolizumab Combined with Standard Chemo-Radiotherapy for Newly Diagnosed Glioblastoma Multiforme Patients

    Recruiting

    3 1 1 1
    Investigated drugs:
    Poland
  • Study on the Safety and Effectiveness of Patritumab Deruxtecan for Patients with Colorectal, Biliary Tract, and Liver Cancer

    Recruiting

    1 1 1 1
    Investigated drugs:
    France Italy Spain
  • Study of Drug Combination for Advanced Cancer Patients with Known Molecular Profile – FINPROVE Study

    Recruiting

    2 1 1 1
    Investigated diseases:
    Finland
  • Study on the Effects of Methylprednisolone and Prednisone for Treating Acute Flare-Ups in Idiopathic Pulmonary Fibrosis Patients

    Recruiting

    2 1 1
    Investigated diseases:
    France
  • Study of OSE-279 and OSE2101 Drug Combination for Patients with Advanced Solid Tumors, Lymphomas, or Metastatic Non-Small Cell Lung Cancer

    Recruiting

    2 1 1
    Belgium France Spain
  • Study Comparing Dostarlimab with CAPEOX and CAPEOX Alone for Patients with Untreated Stage III Colon Cancer

    Recruiting

    2 1 1 1
    Investigated diseases:
    Belgium Italy Spain
  • Study on Insulin Eye Drops for Treating Persistent Corneal Epithelial Defect in Patients with Neurotrophic or Chronic Ocular Surface Diseases

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain
  • Study on Sclerotherapy for Hydrocele and Spermatocele Using Lauromacrogol 400 and Ethanol in Adult Patients

    Recruiting

    3 1 1 1
    Investigated diseases:
    Sweden
  • Study of drug combination therapy for high-risk medulloblastoma in patients over 3 years of age: carboplatin, cisplatin, cyclophosphamide, lomustine, temozolomide, thiotepa, vincristine

    Recruiting

    3 1 1 1
    Investigated diseases:
    Austria Belgium Czechia Denmark Finland Germany +4
  • Study on Apixaban for Blood Clot Prevention in New Multiple Myeloma Patients and Those Having Knee Replacement Surgery

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

powered by